Table 3 Baseline laboratory values of study participants

Hemorheological parameters

 Hematocrit (%)

38.3 ± 4.4

 Hemoglobin—g/dL (g/L)

10.6 ± 1.4 (106 ± 14)

 RBC count—M/μL

4.48 ± 0.59

 WBC count—k/μL

7.1 ± 2.0

 Fibrinogen—mg/dL (g/L)

351 ± 109 (3.51 ± 1.09)

 Total protein (g/dL) (g/L)

7.0 ± 0.5 (70 ± 5)

 Albumin (g/dL) (mmol/L)

4.2 ± 0.3 (0.63 ± 0.05)

Lipid measures

 LDL cholesterol—mg/dL (mmol/L)

83.4 ± 45.7 (2.16 ± 1.18)

 Total cholesterol—mg/dL (mmol/L)

149.1 ± 50.5 (3.86 ± 1.31)

 HDL cholesterol—mg/dL (mmol/L)

49 ± 17 (1.27 ± 0.44)

 Non-HDL cholesterol—mg/dL (mmol/L)

104.1 ± 49.4 (2.69 ± 1.28)

 Triglycerides (median [IQR])-mg/dL (mmol/L)

102 [70–152] (1.15 [0.79–1.72])

Glycemic parameters

 Fasting blood glucose—mg/dL (mmol/L)

124 ± 47 (6.88 ± 2.61)

 Hemoglobin A1C—%

7.2 ± 1.1

Whole blood viscosity-cPs

 High shear

4.0 ± 0.6

 Low shear

11.1 ± 2.1

Other

 Serum creatinine—mg/dL (mmol/L)

1.02 ± 0.48 (0.09 ± 0.04)

 eGFR—mL/min/1.73 m²

54.8 ± 8.2